Hospital Miguel Servet -ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2022

  1. Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea

    Cancer, Vol. 128, Núm. 13, pp. 2441-2448

2016

  1. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation

    Immunobiology, Vol. 221, Núm. 1, pp. 40-47